Contact information
Type
Scientific
Primary contact
Dr Dean Jenkins
ORCID ID
Contact details
Cardiff Medicentre
Heath Park
Cardiff
CF14 4UJ
United Kingdom
+44 (0)2920 757744
DJenkins@bmjgroup.com
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Evaluating the effectiveness of using a Diabetes Needs Assessment Tool (DNAT) on health professionals' knowledge of diabetes and self-reported changes in clinical practice: a randomised controlled trial
Acronym
Study hypothesis
Amended as of 26/03/2009:
Aims:
1. To evaluate the effectiveness of using a new online Diabetes Needs Assessment Tool (DNAT) to improve knowledge of how to manage diabetes
2. To evaluate the acceptability of this format of learning
3. To evaluate self-reported changes in clinical practice as a result of this learning
Hypotheses:
1. Four months after being administered the online learning materials, learners in the intervention group will show greater diabetes knowledge and report higher levels of acceptability of the learning materials than learners in the control group
2. Five months after being administered the online learning materials, learners in the intervention group will report more changes to their clinical practice than learners in the control group
Initial information at the time of registration:
Aims:
1. To evaluate the effectiveness of using a new online Diabetes Needs Assessment Tool (DNAT) to improve knowledge of how to manage diabetes
2. To evaluate the acceptability of this format of learning
3. To evaluate self-reported changes in clinical practice as a result of this learning
Hypotheses:
1. Four months after being administered the online learning materials, learners in the intervention group will show greater knowledge change and report higher levels of acceptability of the learning materials than learners in the control group
2. Five months after being administered the online learning materials, learners in the intervention group will report more changes to their clinical practice than learners in the control group
Ethics approval
As of 11/02/2009 the REC for Wales has confirmed that the study does not require full ethical review
Study design
Multicentre randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Diabetes
Intervention
Both the control group and the intervention group will be given access to the same online Diabetes Learning Modules during a 4-month learning period. The Diabetes Learning Modules include:
1. Current evidence-based guidelines (particularly those of the European Society of Cardiology and the European Association for the Study of Diabetes [ESC-EASD] Guidelines on Diabetes, Pre-diabetes and Cardiovascular Disease)
2. Important clinical areas and common difficulties in practice
3. Type 1, Type 2, diabetes in pregnancy and secondary causes of diabetes
All content of these learning modules is applicable to European practice and material comes from BMJ Learning, Elsevier Health Sciences and the International Diabetes Federation.
In addition to the Diabetes Learning Modules, the intervention group will be administered the Diabetes Needs Assessment Tool (DNAT). The DNAT is a computerised adaptive test comprised of clinically rich case problems. On completion of the DNAT, a personalised learning report is created for each learner identifying their learning needs alongside individualised recommendations of the most appropriate Diabetes Learning Modules to meet those needs. At any stage this personalised report can be viewed listing the performance of the learner at that point.
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measures
Amended as of 26/03/2009:
Diabetes knowledge as measured by the Diabetes Knowledge Test at four months.
Initial information at the time of registration:
Change in knowledge scores on the Diabetes Knowledge Test from baseline (randomisation) to 4 months after administration of learning materials.
Secondary outcome measures
1. Acceptability of the learning materials measured by an electronic survey 4 months after being administered the learning materials
2. Self-reported changes in clinical practice measured by an electronic survey 5 months after being administered the learning materials
Overall trial start date
06/02/2009
Overall trial end date
25/09/2009
Reason abandoned
Eligibility
Participant inclusion criteria
Participants must be either English or German speaking practising doctors or nurses (approximately 20 - 65 years, either sex) managing at least one patient with diabetes a week.
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
200
Participant exclusion criteria
Doctors and nurses not managing at least one patient with diabetes a week.
Recruitment start date
06/02/2009
Recruitment end date
25/09/2009
Locations
Countries of recruitment
Germany, United Kingdom
Trial participating centre
Cardiff Medicentre
Cardiff
CF14 4UJ
United Kingdom
Sponsor information
Organisation
BMJ Group (UK)
Sponsor details
c/o Mrs Vanessa Edmonds
BMA House
Tavistock Square
London
WC1H 9JR
United Kingdom
+44 (0)20 7383 6567
vedmonds@bmjgroup.com
Sponsor type
Industry
Website
Funders
Funder type
Industry
Funder name
Merck Sharp and Dohme Regional Business Support Center (MSD RBSC) GmbH (Germany) - involved in design of study but no access to data or statistical analyses
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Funder name
BMJ Group (UK) - not involved in statistical analyses
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary
2009 protocol in https://www.ncbi.nlm.nih.gov/sites/pubmed/19642984
2011 results in https://www.ncbi.nlm.nih.gov/pubmed/21679446